The MedicX Fund Limited Issue of ordinary shares (5973E)
May 09 2017 - 5:13AM
UK Regulatory
TIDMMXF
RNS Number : 5973E
The MedicX Fund Limited
09 May 2017
For immediate release
9 May 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Issue of ordinary shares
MedicX Fund Limited announces that earlier today, Tuesday 9 May
2017, it issued for cash 1,850,000 ordinary shares of no par value
in the Company. The ordinary shares were issued under the Company's
block listing facility, at a price of 88.75 pence per share.
The net proceeds raised will be used in further pursuing the
investment objectives of the Company.
Total voting rights
In accordance with the Financial Conduct Authority's Disclosure
and Transparency Rules, the total number of ordinary shares in the
capital of the Company in issue following this transaction will be
426,114,107 (excluding treasury shares) each with one voting
right.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest
in the Company, under the Disclosure and Transparency Rules.
The Company also holds 7,619,893 ordinary shares in treasury and
has 2,268,399 ordinary shares of no par value remaining under its
block listing facility to be used to satisfy demand that cannot be
met through the secondary market.
- End -
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Canaccord Genuity +44 (0) 20 7523 8000
Andrew Zychowski/Helen Goldsmith
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Victoria Hayns
Information on MedicX Fund Limited
MedicX Fund Limited (the "Fund" or the "Company", or together
with its subsidiaries, the "Group") is the specialist primary care
infrastructure investor in modern, purpose-built primary healthcare
properties in the United Kingdom and Ireland, listed on the London
Stock Exchange, with a portfolio comprising 156 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP6 billion of funds for more than 50,000 retail and institutional
investors.
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOESSFSUUFWSEFI
(END) Dow Jones Newswires
May 09, 2017 05:13 ET (09:13 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2023 to Apr 2024